Frank Staud assumes overall responsibility for the STADA brand and communications

17/10/2017


Frank Staud assumes overall responsibility for the STADA brand and communications

Bad Vilbel, October 17, 2017 –

Frank Staud assumed the role of Executive Vice President Corporate Communications, Branding and Sponsoring on October 1. The 48-year old Austrian is responsible not only for the image of the STADA brand, but also for all of the Group’s communication activities. These include corporate and product communication, change communication as well as external and internal communication. They also include branding and sponsoring. Staud reports directly to Chairman of the Executive Board Dr. Claudio Albrecht. “STADA currently finds itself in midst of the biggest transformation phase in its history. Outstanding internal and external communication is therefore of utmost importance”, says Albrecht. “I am therefore extremely pleased that we have been able to attract Frank Staud, a proven expert, for this important task – someone who is also a specialist in change communication.”

Staud has more than 20 years of experience in journalism and communications, most recently at the Austrian real-estate company PEMA Group where he held the position of Chief Marketing Officer. From 2010 until 2013 he was with pharmaceutical company Actavis, the world’s fourth largest generics manufacturer, as Executive Vice President Corporate Communications responsible for internal and external communications as well as branding and sponsoring. The Innsbruck native’s roots are in journalism. From 1999 until 2008 Staud served in various functions with the Tiroler Tageszeitung, including more than three years as Editor in Chief.    

Frank Staud, Executive Vice President
Corporate Communications of
STADA Arzneimittel AG
(Credit: Bernd Roselieb, Frankfurt)
Download

Contact:
STADA Arzneimittel AG / Investor Relations / Leslie Iltgen / Stadastraße 2–18 / 61118 Bad Vilbel – Germany / Tel.: +49 (0) 6101 603-173 / Fax: +49 (0) 6101 603-215 / E-mail: leslie.iltgen@stada.de
Download in PDF format

Share:

Related Posts

STADA records further growth in the first nine months of 2016 – Adjusted net income of at least Euro 180 million now expected for full year 2016
STADA records further growth in the first nine months of 2016 – Adjusted net income of at least Euro 180 million now expected for full year 2016
STADA Arzneimittel AG: Announcement of the results of the Tender Offer regarding the STADA-Bond 2015/2022
STADA Arzneimittel AG: Announcement of the results of the Tender Offer regarding the STADA-Bond 2015/2022
STADA: Voting results of the bondholders’ meeting on July 17, 2018 concerning the STADA-Bond 2015/2022: Appointment of One Square Advisory Services GmbH as joint representative and adjournment of the further agenda items
STADA: Voting results of the bondholders’ meeting on July 17, 2018 concerning the STADA-Bond 2015/2022: Appointment of One Square Advisory Services GmbH as joint representative and adjournment of the further agenda items